Company head Rasit Dinc said the veins will be used if animal trials and clinical studies are successful.
INVAMED-RD Global announced in a statement on Tuesday that it produced artificial veins in laboratories using interdisciplinary research and advanced health technologies developed by expert engineers and scientists. They will be employed in cardiovascular and neurovascular patients, enabling them to live their lives without using medicines that help prevent blood clots.The artificial veins were created using high-temperature Teflon technology, biopolymer, and 3D bioprinters. They can fully attach to living tissue, constituting a significant advancement in medical technology that gives hope to patients awaiting organ transplantation.
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:
👏👏👏👏